BPL Medical Tech to scale up global presence, aims to break even in FY19

In all likelihood, FY19 is going to be a milestone year for BPL Medical Technologies. The company is zeroing in on another global acquisition as it targets to cross Rs 1000 crore in revenue by 2022. The acquisition can either be in devices or consumable space, and the company is looking at investing anywhere between Rs 50 crore to Rs 100 crore for this acquisition. The focus area now is not to add more products into the basket but go deeper into each product range and control a high market share. In 2015, BPL Medical Technologies did its first overseas acquisition when it bought UK-based Penlon, a leading manufacturer of anesthesia systems and vaporizers. Since then, the company is learned to have invested around Rs 150 crore into this 75-year-old brand which has shown its manufacturing presence in the UK. The overseas market, mostly Europe, is a small part of BPL Medical Tech’s overall revenues today with a share of around 3 percent, which the company is expecting to raise to 20 percent by 2022. The company has started eyeing Nepal, Bangladesh, African nations, and Eastern Europe which they believe have the potential to become large markets for them.